EX-23.1 4 a05-15058_1ex23d1.htm EX-23.1

 

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-02441, 333-07661, 333-15819, 333-22153, 333-31795, 333-48042, 333-48385, 333-57234 and 333-100123 and Form S-8 Nos. 333-122553, 333-41534, 333-73544, 333-47543, 333-53292, 333-75372 and 333-75374) of ImmunoGen, Inc. and in the related Prospectuses of our reports dated August 17, 2005, with respect to the consolidated financial statements and financial statement schedule of ImmunoGen, Inc., ImmunoGen, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of ImmunoGen Inc., included in the Annual Report (Form 10-K) for the year ended June 30, 2005.

 

 

 

/s/ Ernst & Young LLP

 

 

Boston, Massachusetts

August 22, 2005